CS
APGE icon

Candriam SCA’s Apogee Therapeutics APGE Stock Holding History

Candriam SCA’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.8M Buy
223,541
+32,223
+17% +$2.34M 0.1% 203
2025
Q4 		$14.4M Buy
191,318
+65,237
+52% +$4.11M 0.07% 221
2025
Q3 		$5.01M Buy
+126,081
New +$4.81M 0.03% 368
2025
Q1 		– Sell
-85,661
Closed -$3.88M – 678
2024
Q4 		$3.88M Sell
85,661
-4,339
-5% -$221K 0.02% 394
2024
Q3 		$5.29M Hold
90,000
– – 0.03% 353
2024
Q2 		$3.54M Hold
90,000
– – 0.02% 394
2024
Q1 		$5.98M Buy
+90,000
New +$3.93M 0.04% 314

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return